Welcome to our dedicated page for Bunge Global SA SEC filings (Ticker: BG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bunge Global SA (NYSE: BG) SEC filings page brings together the company’s regulatory disclosures, giving investors and analysts direct access to the documents that explain its agribusiness and food operations in detail. As a Swiss-incorporated issuer with registered shares listed on the New York Stock Exchange, Bunge files annual, quarterly and current reports with the U.S. Securities and Exchange Commission under Commission File Number 000-56607.
Through Forms 10-K and 10-Q, Bunge provides information on its segments, including Agribusiness, Refined and Specialty Oils, Milling and Corporate and Other, and, more recently, its value-chain-based segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. These reports describe how Bunge’s grain origination, oilseed processing and refining, and milling activities contribute to its results, and present both GAAP and non-GAAP metrics such as Segment EBIT and Adjusted Total EBIT.
Current reports on Form 8-K offer timely updates on material events, including earnings releases, changes in segment reporting, capital markets transactions, amendments to revolving credit agreements, expansions of commercial paper and securitization programs, and share capital changes following repurchases. Filings also document governance matters, such as executive transitions and amendments to the Articles of Association.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand changes in Bunge’s capital structure, liquidity facilities, segment performance and risk disclosures. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K and related exhibits appear promptly, while insider transaction reports on Form 4, when filed, can be used to monitor trading by directors and officers. This combination of primary documents and AI explanations allows users to navigate Bunge’s complex agribusiness value chains through its official SEC record.
Schedule 13D Overview: On 2 July 2025 the closing of the Business Combination Agreement between Bunge Global SA ("BG"; NYSE: BG) and Viterra Limited triggered the filing of this Schedule 13D by Glencore plc, Glencore International AG and their wholly-owned subsidiary Danelo Limited (collectively the "Reporting Persons").
Equity Position: Danelo received 32,806,103 registered shares of BG, representing 16.4 % of BG’s 200,042,383 outstanding shares. Voting and dispositive power over the entire block is shared among the three Reporting Persons; none has sole power.
Consideration Paid / Received: In exchange for its pro-rata Viterra stake, Danelo accepted the BG shares plus $895,010,954.48 in cash on the closing date. No other consideration is disclosed.
Shareholder Agreement Highlights:
- Board representation: while ownership ≥10 % Glencore can nominate two directors; while 5–10 % it can nominate one.
- Lock-up: customary one-year transfer restriction, with limited exceptions.
- Stand-still: Glencore capped at 19.9 % ownership until its stake falls below 7 %.
- Transfer limits: no sales to competitors or activist investors; non-compete and non-solicitation last until the later of 3 years post-close or 6 months after Glencore has no board seat.
Registration Rights Agreement: BG must file a resale shelf registration covering the 32.8 million shares and must facilitate underwritten or block trades upon Danelo’s request. These rights terminate the earlier of seven years after closing or once Danelo no longer holds registrable securities.
Purpose of Transaction: The stake is described as an investment. However, the Reporting Persons reserve the right to buy or sell BG securities, engage in hedging, and consult with BG’s management, subject to the Shareholder Agreement restrictions.
Control & Governance: At BG’s 15 May 2025 AGM shareholders elected Christopher Mahoney and Markus Walt—both Danelo nominees—to the board effective at closing, giving Glencore immediate board-level influence.
Key Take-aways for Investors:
- Glencore emerges as BG’s largest single shareholder with a blocking minority below 20 %.
- One-year lock-up mitigates immediate share-overhang risk, but registration rights create potential medium-term liquidity events.
- Board presence may shape post-merger integration and strategic direction.
- Stand-still reduces the likelihood of a near-term control contest.
Bunge Global SA (NYSE: BG) filed an 8-K to report the expiration and final results of a series of debt Exchange Offers and related Consent Solicitations conducted by its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC).
- Scope: The offers covered any and all of Viterra Finance B.V.’s outstanding 2.000% 2026, 4.900% 2027, 3.200% 2031 and 5.250% 2032 notes (collectively, “Existing Viterra Notes”).
- Consideration: Holders were eligible to receive up to US$1.95 billion aggregate principal of new BLFC notes (guaranteed by Bunge) plus cash.
- Indenture Amendments: Consents sufficient to strip certain covenants, restrictive provisions and events of default, and to release Viterra guarantees, were obtained by the early tender deadline of 20 Sep 2024; supplemental indentures were signed 23 Sep 2024 and will become operative at settlement.
- Timing: Exchange Offers expired at 5:00 p.m. (NYC) on 3 Jul 2025; settlement is expected 8 Jul 2025.
- Condition precedent satisfied: Bunge closed its acquisition of Viterra on 2 Jul 2025, fulfilling the principal condition for the offers.
The transaction streamlines the capital structure inherited from Viterra, migrates the debt stack to Bunge’s financing platform and removes legacy covenant restrictions, positioning the combined entity for operational integration. Forward-looking statements and customary legal disclaimers are included. Exhibit 99.1 contains the detailed press release.